Physician

Aravinda Nanjundappa, MD

According to 2025 Medicare claims, Aravinda Nanjundappa, MD (NPI: 1447244488) practices interventional cardiology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Nanjundappa is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), CHSPSC ACO 6, LLC (ACO ID: A3712), Vandalia Health Network (ACO ID: A4513), and Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Nanjundappa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 242 traditional Medicare patients, billed 558 HCPCS/CPT codes, and received $60,165 in Medicare payments. The top billing code was 93454 (Insertion of tube in coronary artery for diagnosis with review by radiologist). Part D data shows 1,115 prescription claims across 276 beneficiaries totaling $178,474 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 101 records totaling $136,760. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $137,962 to $60,165. In contrast, Part D prescription costs have moved sharply higher in recent years, from $19,915 to $178,474. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,311	2,290	$137,962
2016	966	1,596	$126,546
2017	880	1,318	$135,945
2018	1,039	1,603	$183,310
2019	1,025	1,573	$149,843
2020	781	1,191	$143,462
2021	534	796	$61,728
2022	290	623	$68,241
2023	220	540	$60,113
2024	242	558	$60,165

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	133	787	$19,915
2016	96	722	$25,213
2017	122	693	$20,606
2018	110	563	$25,746
2019	124	587	$49,586
2020	121	491	$35,566
2021	111	466	$38,100
2022	196	515	$65,166
2023	234	872	$180,875
2024	276	1,115	$178,474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93454	Insertion of tube in coronary artery for diagnosis with review by radiologist	39	39	$158
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	54	58	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	76	84	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	47	51	$46
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	36	37	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	45	3,330	$63,406
Entresto	Sacubitril/Valsartan	32	1,680	$36,863
Xarelto	Rivaroxaban	15	870	$16,945
Eliquis	Apixaban	11	690	$13,091
Brilinta	Ticagrelor	22	840	$12,415

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$52,872	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	18	$83,888	Inari Medical, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aravinda Nanjundappa, MD?

Tedicare shows public-source Medicare data for Aravinda Nanjundappa, MD (NPI 1447244488), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aravinda Nanjundappa, MD have ACO affiliation data?

Aravinda Nanjundappa, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729), CHSPSC ACO 6, LLC (MSSP, ACO ID A3712), Vandalia Health Network (MSSP, ACO ID A4513), and Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Aravinda Nanjundappa, MD?

Aravinda Nanjundappa, MD is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Aravinda Nanjundappa, MD have Open Payments data?

Aravinda Nanjundappa, MD has 101 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.